Administering the P-3 via telehealth
Click here for general information about telehealth from Pearson Clinical Assessment.
Special recommendations for administering the P-3 via telehealth
Administering the Patient Pain Profile (P-3®) in a telehealth context can be accomplished utilizing our Q-global® software system. Details regarding the system and how it is used are provided on the Q-global product page.
Conducting a valid assessment in a telehealth modality requires an understanding of the interaction between a number of complex issues. In addition to the general information on our telehealth overview page noted above, professionals should address five themes (Eichstadt et al. 2013) when planning for administering P-3® assessments via telehealth:
For more information on the five themes, please visit our general telehealth web page.
Theme-specific information for forced-choice assessment administrations and the P-3
Selected research to date
Please refer to the following studies regarding the appropriateness of administering forced-choice assessments via computer or other electronic means.
Chuah et al (2006). Personality Assessment: Does the Medium Matter? No. Journal of Research in Personality, 40-4, 339-376.
Butcher, J., Perry, J., & Hahn, J. (2004). Computers in clinical assessment: Historical developments, present status, and future challenges. Journal of Clinical Psychology, 60, 331-345.
Pinsoneault, Terry B. (1996) Equivalency of computer-assisted and paper-and-pencil administered version of the Minnesota Multiphasic Personality Inventory-2.Computers in Human Behavior, 12-2, 291-300.
Russell M. et al (2003). Computer-Based Testing and Validity: A Look Back and into the Future. Technology and Assessment Study Collaborative, Boston College
Studies supporting the equivalency of test scores when picture stimuli are displayed to the examinee in a printed manual versus a digital display on a computer screen (in-person administration):
Daniel, M. H., Wahlstrom, D., & Zhou, X. (2014). Equivalence of Q-interactive and paper administrations of language tasks: Selected CELF-5 tests. Q-interactive Technical Report 7. Bloomington, MN: Pearson.
Daniel, M. H. (2012a). Equivalence of Q-interactive administered cognitive tasks: WAIS–IV. Q-interactive Technical Report 1. Bloomington, MN: Pearson.
Daniel, M. H. (2012b). Equivalence of Q-interactive administered cognitive tasks: WISC–IV. Q-interactive Technical Report 2. Bloomington, MN: Pearson.
Conclusion
Provided that you have thoroughly considered and addressed all five themes and the special considerations as listed above, based on the available research, the examiner should be prepared to observe and comment about the reliable and valid delivery of the test via telehealth. Document in your report that the administration was completed by telehealth. You may use the P-3 via telehealth without additional permission from Pearson in the following published context:
- P-3 On-Screen Administration (OSA) or Remote On-Screen Administration (ROSA) via Q-global [tests with OSA/ROSA options]
OR
- P-3 On-Screen Administration (OSA) via Q-global [tests with OSA-only option]
Any other use of the P-3 via telehealth requires prior permission from Pearson.
![Using Q-global digital stimulus books and manuals](/content/dam/school/global/clinical/us/images/225x450-telepractice-pictogram.png)
A customer reflects on using Q-global digital stimulus books and manuals:
Q-Global has been a great solution for us. Managing testing materials between a variety of sites and districts could be very tricky. The online testing materials have completely resolved any access challenges we faced. Observing and recording the client's response through telehealth continues to require a good deal of coordination- particularly for pointing activities. However, the clinician being able to directly manage test stimuli and present them to the client through screen share technology makes that process much less cumbersome.
Thank you for being so proactive with making your tools accessible to telepractitioners!
Nate Cornish, MS, CCC-SLP
Clinical Director
VocoVision